By day 14, VVL-GL7 intervention induced robust expansion of central/effector memory T-cell reservoirs (CD4+/CD8+ TCM/TEM subsets), with CD8+ TEM populations showing pronounced spatial accumulation in both tumor tissue and the spleen, providing evidence of persistent immune memory within the tumor microenvironment [58,59]. The gene discussed is CD4; the disease is neoplasm.